Endpoint Adjudication Monitoring

Endpoint Adjudication Monitoring is a formal oversight process in clinical trial methodology whereby an independent review panel systematically evaluates and confirms the validity, consistency, and adherence to predefined criteria of clinical endpoints to ensure scientific integrity and reduce bias in trial outcomes.

7

Publications

147

Citations

92

Authors

84

Institutions

Publications per year

2017–2026

6

Publications

7

1–5 of 7

Authors

92

  1. FP
    Flora Peyvandi

    University of Milan, Italy

    3 publications · 77 citations

    3

    h-index

  2. CS
    Cristina Solomon

    Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, Austria

    3 publications · 77 citations

    3

    h-index

  3. SK
    Sigurd Knaub

    Octapharma (Switzerland), Switzerland

    3 publications · 77 citations

    3

    h-index

  4. CD
    Claudia Djambas Khayat

    Hôtel-Dieu de France, Lebanon

    3 publications · 77 citations

    3

    h-index

  5. BA
    Bruce A. Schwartz

    Octapharma (United States), United States

    3 publications · 77 citations

    3

    h-index

1–5 of 92

Venues

  1. BMJ Open

    2 publications · 39 citations

    2

    h-index

  2. Journal of Thrombosis and Haemostasis

    JTH · 1 publications · 34 citations

    1

    h-index

  3. Haemophilia

    1 publications · 19 citations

    1

    h-index

  4. International Journal of Cardiology

    1 publications · 16 citations

    1

    h-index

  5. ESC Heart Failure

    1 publications · 15 citations

    1

    h-index

1–5